当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Cardiovascular Drugs and Therapy杂志
Cardiovascular Drugs and Therapy
基本信息
期刊名称 Cardiovascular Drugs and Therapy
CARDIOVASC DRUG THER
期刊ISSN 0920-3206
期刊官方网站 https://www.springer.com/10557
是否OA No
出版商 Kluwer Academic Publishers
出版周期 Bimonthly
文章处理费 登录后查看
始发年份 1987
年文章数 101
影响因子 3.1(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学3区 CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统3区
PHARMACOLOGY & PHARMACY 药学3区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 8.3 0.973 0.814
Medicine
Pharmacology (medical)
35/272 87%
Medicine
Cardiology and Cardiovascular Medicine
57/387 85%
Pharmacology, Toxicology and Pharmaceutics
Pharmacology
65/313 79%
补充信息
自引率 3.2%
H-index 63
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0920-3206%5BISSN%5D
投稿指南
期刊投稿网址 https://www.editorialmanager.com/cdty/
收稿范围
Designed to objectively cover the process of bench to bedside development of cardiovascular drug, device and cell therapy, and to bring the most necessary information in a timely and concise format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic field.

Homing in on the most exciting work being done on new therapeutic agents, Cardiovascular Drugs and Therapy focuses on developments in treatment of hyperlipidemia, diabetes and other cardiometabolic conditions, atherosclerosis, ischemic syndromes, heart failure, cardiomyopathies, valvular heart disease, and arrhythmias. These include mechanisms of action and signaling pathways, their potential for new drug development, novel indications for older drugs, genetic approach to treatment, and new directions in device and cell therapy, interventional and structural heart disease, and cardiac and vascular surgery, as well as their guideline-based utilization in real-world patient populations. The Journal is an authoritative source of current and relevant information that is indispensable for basic and clinical investigators aiming for novel, breakthrough research as well as for cardiologists seeking to best serve their patients.

Cardiovascular Drugs and Therapy is listed in Web of Science and PubMed/Medline among other abstracting and indexing services. The regular articles and frequent special topical issues provide an up-to-date source defined by the need for accurate information on an ever-evolving field. Cardiovascular Drugs and Therapy is a careful and accurate guide for clinicians and researchers to navigate new products and therapies in cardiovascular pharmacology that will remain an essential and timeless resource.
收录体裁
投稿指南 https://link.springer.com/journal/10557/submission-guidelines
投稿模板
参考文献格式
编辑信息

Editors-in-Chief:
Willem J. Remme,
 Rhoon, The Netherlands

Founding Editors:
Henry N. Neufeld
Lionel H. Opie

Associate Editors:
Juan J. Badimon, 
New York, USA
Yochai Birnbaum, Houston, USA
Y. Eugene Chen, Ann Arbor, USA
Kim A. Connelly, Toronto, Canada 
Harry J.G.M. Crijns, Maastricht, The Netherlands
Sean Davidson, London, UK
Michael Farkouh, Toronto, Ontario, Canada
John Horowitz, Adelaide, Australia
Juan Carlos Kaski, London, UK
Masafumi Kitakaze, Osaka, Japan
Wolfgang Koenig, Ulm Germany
Jay Mehta, Little Rock, Arkansas, USA
Bertram Pitt, Ann Arbor, USA
Carol-Ann Remme, Amsterdam, The Netherlands
Robert S. Rosenson, New York, NY, USA
Derek So, Ottawa, Canada

BASIC PHARMACOLOGY

Adolfo Garcia-Ocaña, New York, NY, USA
David Grieve, Belfast, UK
Barbara Huisamen, Tygerberg, South Africa
Qing Jing, Shanghai, China
Thomas Krieg, Cambridge, UK
Wei Kong, Beijing, China
Robert Lasley, Detroit, Michigan, USA
Roberto Latini, Milan, Italy
David J. Lefer, Atlanta, USA
Amanda Lochner, Stellenbosch, South Africa
Gary Lopaschuk, Edmonton, Canada
Hani Sabbah, Detroit, Michigan, USA
Robert Schwinger, Weiden, Germany
Joss du Toit, Southport, Australia
Thomas Unger, Berlin, Germany
Nanping Wang, Beijing, China
Gemma Vilahur, Barcelona, Spain
Huang-Tian Yang, Shanghai, China
Hou-Zao Chen, Beijing, China
Lemin Zheng, Beijing, China
Yi Zhu, Beijing, China

CLINICAL PHARMACOLOGY, DRUGS AND DEVICES

Masanori Asakura, Osaka, Japan
Lina Badimon, Barcelona, Spain
Eric Bruckert, Paris, France
Josep Brugada, Barcelona, Spain
Alberto Corsini, Milan, Italy
Jan Danser, Rotterdam, The Netherlands
Jie Du, Beijing, China
Masatsugu Hori, Osaka, Japan
Yu Huang, Hong Kong, China
John McNeil, Melbourne, Australia
Marco Metra, Brescia, Italy
Sascha N. Goonewardena, Ann Arbor, MI, USA
Thomas Szucs, Zürich, Switzerland
Juan Tamargo, Madrid, Spain
Dimitrios Tziakas, Alexandroupolis, Greece
Rajesh Vedanthan, New York, NY
Adriaan Voors, Groningen, The Netherlands
Aimin Xu, Hong Kong, China
Cheuk-Man Yu, Shatin, Hongkong
Yunzeng Zou, Shanghai, China
Coert J. Zuurbier, Amsterdam, The Netherlands

CLINICAL TRIALS 

Dimitrios Alexopoulos, Athens, Greece
Inder Anand, Minneapolis, Minnesota, USA
Andreas Goette, Magdeburg, Germany
Aldo Maggioni, Milan, Italy
Luis Ruilope, Madrid, Spain
Mandeep Sidhu, Albany, NY
Mark Talan, Baltimore, USA

Editorial Assistant: Noor van Dam, Rhoon, The Netherlands


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug